Resmed Inc. buy Needham & Company LLC
Start price
06.09.23
/
50%
€143.10
Target price
06.09.24
-
Performance (%)
55.49%
End price
07.09.24
€222.50
Summary
This prediction ended on 07.09.24 with a price of €222.50. The BUY prediction by Needham___Company_LL for Resmed Inc. saw massive gains of 55.49%. Dividends of €1.82 are taken into consideration when calculating the performance. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 10.707% | 10.707% | -22.183% |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten